Medicus Pharma Ltd. has filed a resale registration covering up to 4,020,000 common shares issuable on exercise of existing Private Warrants held by Armistice Capital Master Fund Ltd. Each warrant is immediately exercisable for one common share at an exercise price of $2.00 and expires on June 5, 2031.
The company is not selling shares in this registration and will not receive proceeds from resales by the selling shareholder, though it may receive up to $8,040,000 if the warrants are exercised for cash. Common shares trade on Nasdaq under “MDCX,” and the company qualifies as an emerging growth and smaller reporting company.
Medicus Pharma Ltd. filed an offering circular supplement dated September 18, 2025 registering 1,490,000 common shares issuable upon the exercise of outstanding warrants.
Concurrently, the company entered into a securities purchase agreement with YA II PN, Ltd. (Yorkville) for a $8,000,000 debenture. Net proceeds were approximately $5.7 million after satisfaction of an existing $1.7 million debt balance and fees. The Debenture bears interest at 8.00% per annum (increasing to 18.00% upon certain defaults), matures on September 17, 2026, and requires monthly repayments of $650,000 plus accrued interest beginning 45 days after issuance. Each subsidiary entered into a global guaranty in favor of Yorkville.
Medicus Pharma Ltd. entered into a new financing deal with YA II PN, Ltd. (Yorkville), issuing a debenture with a principal amount of $8,000,000. The company received approximately $5.7 million in net proceeds after using about $1.7 million to fully repay remaining debentures from a May 2025 financing and accounting for original issue discount and fees. The debenture carries 8.00% annual interest, which can increase to 18.00% if certain events of default occur, and matures on September 17, 2026. Medicus must make monthly payments of $650,000 plus accrued interest in cash starting 45 days after issuance, with any remaining balance due at maturity. All company subsidiaries entered into a global guaranty in favor of Yorkville, and the company may redeem the debenture early in cash, in whole or in part.